
Keith Abraham saw a problem: too many veterans were slipping through the cracks.
After experiencing the benefits of psychedelic treatment firsthand, he knew he could help. So, he made a bold move: swapping his corporate career at J.P. Morgan to build a startup, one that uses drugs still considered Class A in the UK.
In this episode, Keith shares his journey from finance to the forefront of psychedelic therapy for veterans. It’s a powerful story of purpose, risk, and a mission unlike any other.